A Biogen employee with symptoms of the novel coronavirus COVID-19 was terminated by the company after she left her home in Massachusetts and boarded a plane to China without disclosing her exposure to the virus.

California ordered nearly 40 million people to stay home and New York state on Friday told all non-essential workers to do the same while pleading for more medical personnel and supplies to treat coronavirus cases that could overwhelm hospitals.

Scanwell Health secured exclusive rights to license and distribute a SARS-CoV-2 rapid serology test from INNOVITA for at-home use. The test takes 15 minutes to complete using the Scanwell Health app, and within hours a doctor or nurse practitioner will reach out with results and next steps.

Shares of FujiFilm spiked more than 26 percent after reports that the company’s flu drug favipiravir proved effective in treating coronavirus cases in China.

Days after Roche began shipping hundreds of thousands of the Swiss pharma giant’s recently approved COVID-19 test to laboratories in the United States, the company initiated a late-stage trial assessing the rheumatoid arthritis drug Actemra in patients who have severe COVID-19 caused pneumonia.

The U.S. Food and Drug Administration approved Abbott’s molecular test for the novel coronavirus that causes COVID-19 under an Emergency Use Authorization (EUA).

U.S. researchers, following the lead of scientists in other countries, launched studies to see whether widely available, low-cost generic drugs can be used to help treat the illness caused by the new coronavirus.

Researchers with Scripps Research and other institutions around the globe published a study in the journal Nature Medicine debunking the theory that the novel coronavirus that causes COVID-19 is manmade after an analysis of the genome sequence of SARS-CoV-2.

Celltex Therapeutics Corporation began active discussions with the FDA regarding a study using using adult, autologous Mesenchymal Stem Cells against coronavirus (COVID-19)-type symptoms.

As the world waits with bated breath for a treatment for COVID-19, all eyes are on Gilead Science’s antiviral drug remdesivir as a potential candidate.